Atlas Trials

Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer

Clinical trial NCT03290508 · TERMINATED

Trial details

NCT number
NCT03290508
Sponsor
Myriad Genetic Laboratories, Inc.
Status
TERMINATED
Study type
OBSERVATIONAL
Prostate Cancer
Start date
2017-09-14
Primary completion
2022-01-14
Enrollment
524

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.